To include your compound in the COVID-19 Resource Center, submit it here.

Neurocrine Phase III indiplon data

NBIX said its indiplon modified release formulation met the primary endpoint of improved patient-reported total sleep time

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE